Buy Cyient; target of Rs 1100: Motilal Oswal

Motilal Oswal is bullish on Cyient recommended buy rating on the stock with a target price of Rs 1100 in its research report dated January 13, 2023.

Broker Research
January 13, 2023 / 03:01 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Motilal Oswal's research report on Cyient


CYL reported 3QFY23 revenue growth of 13.4% QoQ in CC, largely coming through the full-quarter consolidation of Citec. Excluding the inorganic impact, its Services business grew by 3.7% QoQ CC vs our estimates of 3.1% QoQ. DLM grew by 22.8% QoQ, beating our estimate of 18.1% QoQ growth. 3Q growth was led by A&D, Energy and Utility verticals, up 10.2%, 5.8% and 4.6% QoQ, respectively. Communications remained muted. Rail/Consulting stayed weak, declining 4.6%/7.8% QoQ. Management has maintained FY23 organic revenue growth guidance of 13-15% in CC terms. The normalized EBIT margin stood at 12.9%, up 100bp QoQ, beating our estimate of 50bp improvement. Management has maintained its FY23 EBIT margin guidance of 13-14%. Service order intake was strong at USD237m, up 83% QoQ/18% YoY. The deal pipeline also remains healthy, adding to confidence in management’s guidance of delivering better QoQ Service revenue growth in 4QFY23. The challenges in the A&D and Rail segments are behind, and the verticals are expected to reverse the trend to stimulate growth going forward. Rail Transportation bottomed out in Q3 and should aid topline growth in coming quarters. The DLM transaction (Proposed IPO) is expected to get executed by FY24. The DLM carve-out is another trigger that will release enough resources and management bandwidth currently occupied in running the business. We believe the transaction should be positive for the service segment and it should unlock value for both the entities.



Outlook


We have slightly tweaked our estimates to account for better growth. We maintain our Buy rating on the stock on attractive valuations. Our target multiple of 16x FY24E EPS implies a TP of INR1,100, with a potential upside of 25%.


For all recommendations report, click here


Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Cyient - 13 -01-2023 - moti

Broker Research
Tags: #Buy #Cyient #Motilal Oswal #Recommendations
first published: Jan 13, 2023 03:01 pm